Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we wish to inform you that company has entered into a strategic Contract Manufacturing Agreement with a company having top ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Veerhealth Care Ltd has entered into a strategic Contract Manufacturing Agreement with a company that has top-tier clients or products (full details cut off in the headline). The disclosure is being made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements (LODR), 2015, indicating the deal is material to the company. The agreement positions Veerhealth Care as a manufacturing partner for a high-profile brand, potentially adding significant new business volume. No financial terms, deal value, or duration have been disclosed in the available text.
This is a positive development that could expand Veerhealth Care's revenue base and improve utilization of its manufacturing capacity, though the lack of disclosed deal size makes it hard to gauge the stock impact. Investors should watch for further details on the counterparty, contract value, and tenure.